Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fasciani

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Minerva Pediatrica|December 22, 1998
[Menstrual cycle]G D'Ambrogio, M Monti, A Fasciani, et al.
Molecular Human Reproduction|May 23, 1998
Effect of maternal age and conditions of fertilization on programmed cell death during murine preimplantation embryo developmentA Jurisicova, I Rogers, A Fasciani, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 22, 1999
Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndromeG D'Ambrogio, A Fasciani, M Monti, et al.
Fertility and Sterility|June 1, 2001
Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathologyA Fasciani, G D'Ambrogio, G Bocci, et al.
Molecular Human Reproduction|December 28, 1999
High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomataA Fasciani, G D'Ambrogio, G Bocci, et al.
Molecular Human Reproduction|July 27, 2001
In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vesselsG Bocci, A Fasciani, R Danesi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 23, 2002
Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndromeP G Artini, M Monti, A Fasciani, et al.
Fertility and Sterility|October 3, 1998
Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization programP G Artini, A Fasciani, M Monti, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 3, 1998
Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilizationP G Artini, M Monti, A Fasciani, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 1, 1997
Fertility drugs and ovarian cancerP G Artini, A Fasciani, V Cela, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Minerva Pediatrica|December 22, 1998
[Menstrual cycle]G D'Ambrogio, M Monti, A Fasciani, et al.
Molecular Human Reproduction|May 23, 1998
Effect of maternal age and conditions of fertilization on programmed cell death during murine preimplantation embryo developmentA Jurisicova, I Rogers, A Fasciani, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 22, 1999
Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndromeG D'Ambrogio, A Fasciani, M Monti, et al.
Fertility and Sterility|June 1, 2001
Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathologyA Fasciani, G D'Ambrogio, G Bocci, et al.
Molecular Human Reproduction|December 28, 1999
High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomataA Fasciani, G D'Ambrogio, G Bocci, et al.
Molecular Human Reproduction|July 27, 2001
In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vesselsG Bocci, A Fasciani, R Danesi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 23, 2002
Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndromeP G Artini, M Monti, A Fasciani, et al.
Fertility and Sterility|October 3, 1998
Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization programP G Artini, A Fasciani, M Monti, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 3, 1998
Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilizationP G Artini, M Monti, A Fasciani, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 1, 1997
Fertility drugs and ovarian cancerP G Artini, A Fasciani, V Cela, et al.
Pageof 2